AIDS/HIV Vaccine
Program changes needed to introduce vaccines targeted at adolescents
Published in AIDS Weekly, October 11th, 2004
"A safe, effective and accessible preventive vaccine is our best long-term hope for the control of the HIV/AIDS pandemic. Once the first generation of HIV vaccines are developed, many questions remain unanswered regarding their administration. For instance, which vaccines should be given to whom at what age and how many doses' We argue that pre- and early-adolescents will be one of the main target groups for future HIV vaccines, that is, before the age of exposure to the virus," researchers in Australia, South Africa, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-10-11)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV-1 subtypes unchanged among heterosexuals in England and Wales from 1997-2000 - HIV/AIDS Therapy
HIV salvage therapy safe and effective in patients with >200 CD4+ cell counts - HIV/AIDS Therapy
Novel technique monitors safety/efficacy of HIV therapy - HIV/AIDS Therapy
Stereochemistry and regiochemistry of NNRTI profoundly affects anti-HIV activity - Human Immunodeficiency Virus
Targeting of HIV-1 RNA-DNA hybrid structures potential strategy for therapy - AIDS/HIV Therapy
Effort underway to improve the quality of HIV care in U.S. - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
